What You Should Know:Audio-only telehealth visits for both primary care and mental health services remained common at safety net clinics in California since the start of the COVID-19 pandemic, according to a new RAND Corporation…
Continue Reading
What You Should Know:The drug discovery outsourcing market is expected to reach $3.75B in 2023 and is expected to grow at a steady CAGR of 7.2% and is expected to reach $7.52B by 2033, according to…
Continue Reading
by Fred Pennic 04/07/2023 Leave a CommentWhat You Should Know:Biostage, Inc., a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer and FDA approval to commence a clinical trial of the Biostage…
Continue Reading
What You Should Know:– HeartFlow, Inc., a provider of precision heart care raises $215M in Series F funding round led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and…
Continue Reading
What You Should Know:The benefits of public cloud are promising, as many Amazon Web Services (AWS) and Microsoft customers (both provider organizations and vendors) have noted in previous KLAS research. The first health systems…
Continue Reading
What You Should Know:– PsychoGenics Inc., a provider of AI-enabled phenotypic drug discovery and preclinical CRO services launches eCube®, a novel pharmaco-electroencephalography (“pharmacoEEG”) platform.The platform supports phenotypic drug discovery, which unlike traditional target-based drug…
Continue Reading
What You Should Know:– Cognizant expands partnership with Microsoft to give healthcare payers and providers easy access to cutting-edge technology solutions, streamlined claims management, and improved interoperability to optimize business operations and deliver better…
Continue Reading
What You Should Know:– SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO.– Fred will…
Continue Reading
Chris Tackaberry, founder and CEO of ClinithinkCollectively rare diseases are anything but rare – they impact 30 million people in the US and ten times that amount globally. And 1 in 3 children suffering…
Continue Reading
Alyssa Alsheimer, SVP of Marketing and Engagement at WellframeThe first step toward better health outcomes happens when people become proactive about protecting their own health and well-being. Proactive action rarely appears out of nowhere, though — most of…
Continue Reading
